As of May 23, 2026, Cognition Therapeutics's top three insider holders are Memory Spv I, Lp Bios (TenPercentOwner, 3.91Mn shares), Leslie W. Kreis (Director, 2.66Mn shares), Aaron G.L. Fletcher (Director, 2.66Mn shares).
| Holder | Position | Shares (Direct) | Shares (Indirect) | Report Date |
|---|---|---|---|---|
| Lisa Ricciardi | Ceo President | 1,715,851 | 0 | 20 Apr, 2026 |
| Brett P Monia | - | 48,500 | 0 | 23 Jun, 2025 |
| James Michael O'Brien | Chief Financial Officer | 5,000 | 0 | 14 Oct, 2021 |
| Memory Spv I, Lp Bios | - | 1,424,014 | 2,488,827 | 15 Oct, 2021 |
| Aaron G.L. Fletcher | - | 0 | 2,658,387 | 29 Nov, 2022 |
| Leslie W. Kreis | - | 0 | 2,658,387 | 29 Nov, 2022 |
| John Brendan Doyle | Chief Financial Officer | 627,509 | 0 | 20 Apr, 2026 |
| Peggy Wallace | - | 86,461 | 0 | 23 Jun, 2025 |
| Mark H. Breedlove | - | 0 | 404,439 | 15 Oct, 2021 |
| Cap Associates, Llc Ogden | - | 2,210,377 | 0 | 15 Oct, 2021 |
| Anthony Caggiano | Chief Medical Officer | 874,906 | 0 | 20 Apr, 2026 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 16 Apr, 2026 | John Brendan Doyle | Common Stock | A | 10,000 | $1.13 | 627,509 | D | P |
| 16 Apr, 2026 | John Brendan Doyle | Common Stock | A | 10,000 | $1.13 | 627,509 | D | P |
| 16 Apr, 2026 | Lisa Ricciardi | Common Stock | A | 9,175 | $1.10 | 1,715,851 | D | P |
| 16 Apr, 2026 | Anthony Caggiano | Common Stock | A | 10,000 | $1.11 | 874,906 | D | P |
| 15 Feb, 2026 | John Brendan Doyle | Common Stock | D | 1,560 | $1.12 | 617,509 | D | F |
| 15 Feb, 2026 | John Brendan Doyle | Common Stock | D | 1,560 | $1.12 | 617,509 | D | F |
| 15 Feb, 2026 | Lisa Ricciardi | Common Stock | D | 5,850 | $1.12 | 1,706,676 | D | F |
| 15 Feb, 2026 | Anthony Caggiano | Common Stock | D | 4,680 | $1.12 | 864,906 | D | F |
| 15 Feb, 2026 | John Brendan Doyle | Common Stock | D | 1,560 | $1.12 | 617,509 | D | F |
| 03 Feb, 2026 | John Brendan Doyle | Common Stock | A | 200,000 | $0.00 | 645,990 | D | A |
| 03 Feb, 2026 | John Brendan Doyle | Common Stock | A | 200,000 | $0.00 | 645,990 | D | A |
| 03 Feb, 2026 | Lisa Ricciardi | Common Stock | A | 800,000 | $0.00 | 1,790,266 | D | A |
| 03 Feb, 2026 | Anthony Caggiano | Common Stock | A | 400,000 | $0.00 | 907,993 | D | A |
| 03 Feb, 2026 | John Brendan Doyle | Common Stock | A | 200,000 | $0.00 | 645,990 | D | A |
| 03 Feb, 2026 | Anthony Caggiano | Common Stock | D | 11,488 | $1.12 | 896,505 | D | F |
| 03 Feb, 2026 | Lisa Ricciardi | Common Stock | D | 26,036 | $1.12 | 1,764,230 | D | F |
| 04 Feb, 2026 | John Brendan Doyle | Common Stock | D | 26,921 | $1.03 | 619,069 | D | F |
| 04 Feb, 2026 | John Brendan Doyle | Common Stock | D | 26,921 | $1.03 | 619,069 | D | F |
| 04 Feb, 2026 | John Brendan Doyle | Common Stock | D | 26,921 | $1.03 | 619,069 | D | F |
| 04 Feb, 2026 | Lisa Ricciardi | Common Stock | D | 51,704 | $1.03 | 1,712,526 | D | F |